## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `selank-tirzepatide`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/selank-tirzepatide/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/selank-tirzepatide/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/selank-tirzepatide/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/selank-tirzepatide/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/selank-tirzepatide/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/selank-tirzepatide/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `selank-tirzepatide` v2 · content_hash `afc27c3a959f22e5…` · thread_head genesis · 21 DIVs
- **thesis (c1):** Small Russian human trials (n=30-70) showed Selank anxiolytic effects comparable to benzodiazepines without sedation or dependence in GAD patients.
  - c2 [human/active] FAERS analysis found psychiatric adverse events in ~1.18% of GLP-1 agonist reports; anxiety was 38.7% of those events across semaglutide, liraglutide, and tirze
  - c3 [mechanistic/active] No human trials or published data examine Selank combined with tirzepatide.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/selank-tirzepatide/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/selank-tirzepatide/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `selank-tirzepatide`
- **title:** Selank and Tirzepatide: Layered Evidence on Neurochemistry and Metabolic Pathways
- **url:** https://miscsubjects.com/a/selank-tirzepatide
- **register:** source_ledger
- **updated:** 2026-07-17T02:41:42.480Z
- **tags:** peptide, matrix

## Body

## What's breaking down

No single clinical condition is defined by the slug, so the layers come from the two compounds themselves. Tirzepatide targets metabolic load through GLP-1 and GIP receptor agonism, which produces weight loss but can coincide with reported psychiatric adverse events including anxiety in post-marketing data. Selank targets anxiety and neurochemistry pathways. When these two are considered together, the potential overlap is in the neurochemical stress layer that can accompany metabolic shifts.

## Why Selank might help you

1. **What keeps failing:** Chronic stress chemistry, non-restorative arousal states, or anxiety-like symptoms that may appear alongside metabolic therapies.
2. **What Selank is studied to do:** Human trials in Russia examined Selank in patients with generalized anxiety disorder and neurasthenia; it showed anxiolytic effects comparable to low-dose benzodiazepines without sedation, cognitive impairment, or dependence.
3. **Therefore for you:** If the anxiety or neurochemistry layer is part of your experience while using tirzepatide, Selank is discussed in the literature because it targets repair of that specific layer rather than broad suppression.

## Why Tirzepatide might help you

1. **What keeps failing:** Excess body weight creates mechanical and metabolic load on multiple systems.
2. **What Tirzepatide is studied to do:** Large human trials demonstrate substantial weight reduction via dual GLP-1/GIP agonism.
3. **Therefore for you:** If metabolic load contributes to overall strain, tirzepatide is discussed because it addresses that layer through documented weight-loss mechanisms.

## How these fit together

Each compound targets a different degeneration layer. Selank addresses anxiety and neurochemistry repair. Tirzepatide addresses metabolic load and body-weight reduction. The stack maps separate pathways without repetition.

## What the evidence actually shows

Human data for Selank consists of small Russian trials (n=30–70) comparing it to medazepam or phenazepam in generalized anxiety disorder; anxiolytic scores improved similarly but without typical benzodiazepine side effects (Zozulia 2008, Filatova 2017). These are the only published human efficacy studies; no large Western RCTs exist. Preclinical work shows Selank modulates GABA-A receptor subunits and cytokine expression.

For tirzepatide, SURMOUNT and SURPASS trials report robust weight loss and glycemic control in thousands of participants. FAERS analysis of GLP-1 agonists including tirzepatide found psychiatric adverse event reports at ~1.18% of total reports, with anxiety comprising 38.7% of those psychiatric events (Tobaiqy 2024). Case reports describe possible mood improvement in two patients (Psychiatrist.com 2025). No human trials examine Selank plus tirzepatide.

## What scientists say

Russian researchers conclude Selank produces anxiolytic effects comparable to classical benzodiazepines without sedation or dependence (PMC articles 4757669, 5322660). Western reviews note limited sample sizes and lack of independent replication. Tirzepatide researchers focus on metabolic endpoints; psychiatric signals are monitored through pharmacovigilance rather than dedicated neurochemistry trials.

## What people say on Reddit

A single thread in r/Nootropics describes one user combining Selank with semaglutide and reporting improved mood and reduced social anxiety. Broader tirzepatide discussions mention variable mood or anxiety-like sensations tied to GI effects or glucose shifts, with some users switching agents for better tolerability.

## What people say on X

Posts list both compounds among popular research peptides but contain no detailed user experiences of the combination. Mentions are primarily catalog-style references to cognitive or metabolic categories.

## What we do not know

No direct interaction data, long-term human safety data for the pair, or controlled trials exist. Mechanisms by which tirzepatide might influence anxiety pathways remain speculative. Selank’s Western evidence base is small and untranslated in full.

## Safety and limits

Selank is approved in Russia but not elsewhere; human safety data are limited to weeks-to-months durations in small cohorts. Tirzepatide carries known GI and rare psychiatric reporting signals. Any combined use lacks regulatory evaluation. All statements are for informational purposes only.

## Claims (3)

- **c1** [human w=0.8] Small Russian human trials (n=30-70) showed Selank anxiolytic effects comparable to benzodiazepines without sedation or dependence in GAD patients.
  - who_claims: grok/grok-4.3
  - sources: s1, s4
- **c2** [human w=0.8] FAERS analysis found psychiatric adverse events in ~1.18% of GLP-1 agonist reports; anxiety was 38.7% of those events across semaglutide, liraglutide, and tirzepatide.
  - who_claims: grok/grok-4.3
  - sources: s9
- **c3** [mechanistic w=0.3] No human trials or published data examine Selank combined with tirzepatide.
  - who_claims: grok/grok-4.3

## Voxel graph (3 atoms · 6 edges)
- full graph: https://miscsubjects.com/api/articles/selank-tirzepatide/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (3)
- chain valid: yes · head: `31acc61b3b171b7d`

### s1 · pubmed · ok
- title: Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia
- url: https://pubmed.ncbi.nlm.nih.gov/18454096/
- summary: 2008 Russian trial comparing Selank to medazepam in 62 GAD/neurasthenia patients.
- quote: The increase of this parameter and stronger positive correlations with anxiety level were observed during the treatment with selank mostly in patients with GAD.
- claim_ids: c1
- hash: `cf562137a860145e`

### s4 · pubmed · ok
- title: Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC5322660/
- summary: Reviews Selank clinical data versus benzodiazepines.
- quote: Clinical studies have shown that the anxiolytic effect of Selank is comparable to the effect of low doses of the benzodiazepine tranquilizers
- claim_ids: c1
- hash: `1964c13fb8d7e87a`

### s9 · pubmed · ok
- title: Psychiatric adverse events associated with semaglutide, tirzepatide and liraglutide
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC10960895/
- summary: FAERS pharmacovigilance analysis of psychiatric reports for GLP-1 agonists.
- quote: Depression was the most commonly reported adverse event (n = 187; 50.3%), followed by anxiety (n = 144; 38.7%)
- claim_ids: c2
- hash: `31acc61b3b171b7d`

## Provenance (2 model passes)
- chain valid: yes · head: `d8cf2e2e3272b1f1`

- write · grok/grok-4.3 · 2026-06-30T00:34 · hash `8b4b2e51f299`
- voxel_divide · owner · 2026-07-17T02:41 · hash `d8cf2e2e3272`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/selank-tirzepatide/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/selank-tirzepatide/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"selank-tirzepatide","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest selank-tirzepatide|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim selank-tirzepatide|tier|assertion`
- **iMessage ask:** `selank-tirzepatide|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `selank-tirzepatide`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/selank-tirzepatide/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/selank-tirzepatide/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*